M Hamami

1 works

Institute of Nuclear Medicine,

1. 51 RESPONSE RATE ACCORDING TO WHO, RECIST AND EASL CRITERIA AFTER RADIOEMBOLIZATION OF YTTRIUM-90 GLASS MICROSPHERES IN ADVANCED HEPATOCELLULAR CARCINOMA: A EUROPEAN PILOT PHASE II STUDY

   Amr El Fouly, Justin Ertle, G Antoch +5

   ArticleHepatocellular Carcinoma Treatment and PrognosisJournal of Hepatology20090 citations

   ABIABI:AkademIndex/openalex/2009.article.000412